Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · Real-Time Price · USD
2.515
-0.015 (-0.59%)
Mar 31, 2025, 10:22 AM EDT - Market open
Aerovate Therapeutics Market Cap
Aerovate Therapeutics has a market cap or net worth of $72.90 million as of March 31, 2025. Its market cap has decreased by -90.23% in one year.
Market Cap
72.90M
Enterprise Value
-4.87M
1-Year Change
-90.23%
Ranking
Category
Stock Price
$2.52
Market Cap Chart
Since the IPO on June 30, 2021, Aerovate Therapeutics's market cap has decreased from $323.51M to $72.90M, a decrease of -77.47%. That is a compound annual growth rate of -32.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 73.33M | -4.16% |
| Dec 31, 2024 | 76.52M | -87.78% |
| Dec 29, 2023 | 626.15M | -13.15% |
| Dec 30, 2022 | 720.93M | 150.50% |
| Dec 31, 2021 | 287.80M | -11.04% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |